Company Overview of The Jackson Laboratory
The Jackson Laboratory conducts mammalian genetics research in the United States. It offers scientific services and genetic resources to laboratories internationally, and educates students of various ages through courses, internships, and programs. The company also provides scientific resources, techniques, software, and data to scientists internationally. It offers high school internships, pre and post-doctoral opportunities, and collaborative education programs. The company discovers genetic basis for preventing, treating, and curing human diseases in the areas of cancers, computational biology and bioinformatics, developmental and reproductive biology, immunology, metabolic diseases, and ...
600 Main Street
Bar Harbor, ME 04609
Founded in 1929
Key Executives for The Jackson Laboratory
Chief Executive Officer and President
Chief Operating Officer and Executive Vice President
Director of Genetic Resource Science
Chair of Research and Trustee
Compensation as of Fiscal Year 2014.
The Jackson Laboratory Key Developments
The Jackson Laboratory and UC Davis Expand their Fifteen Year Collaboration to Provide Mutual Support in Research Infrastructure and Educational Programs
Feb 25 14
The Jackson Laboratory and UC Davis are expanding their fifteen year collaboration to provide mutual support in research infrastructure and educational programs. The new agreement will enable UC Davis to fully utilize The Jackson Laboratory’s Sacramento-based infrastructure to reduce long-term capital and operating expenses to the University, while providing flexibility to the UC Davis investigators and administration in pursuit of their research results. Under a new memorandum of understanding, the institutions will launch several new initiatives in the coming year: Research Mouse Importation Program: UC Davis intends to recruit hundreds of new researchers over the next decade. JAX will assist newly recruited UC Davis investigators by picking up their mouse colonies at their previous institution, establishing new breeding colonies to meet stringent JAX health standards and then delivering the mice to UC Davis (or holding them at JAX if space is not yet available on the UC Davis campus). This initiative will enable the new investigators to resume their research programs as soon as they arrive on campus, in many cases accelerating their scientific contributions by several months. This strategy also will reduce the level of new capital projects required by the University in an era of tight fiscal constraint. Educational programs: JAX will design and run on-site seminars for proper selection of research models in areas of special interest to UC Davis researchers. UC Davis students, faculty and staff will continue to have access to JAX’s courses, conferences and other educational programs. Research Infrastructure: Both institutions hope to reduce costs by sharing mouse-based core services, such as UC Davis strong imaging capabilities and JAX’s production-scale mouse cryopreservation facilities. The JAX-UC Davis relationship goes back to 1999, when JAX established a small research animal facility on the UC Davis campus to expand the university’s then-new mouse biology program. In the following years, JAX established a mouse-production facility in West Sacramento and moved to larger space in Sacramento in 2009. The two institutions’ collaborations include scientific and clinical research on primary cancer tumor xenografts, collaborations among individual scientists, and projects related to the National Institutes of Health Knockout Mouse Project (known as KOMP).
Karolina Palucka Joins The Jackson Laboratory as Professor and Associate Director of Cancer Immunology
Feb 21 14
A. Karolina Palucka, M.D., Ph.D., will join The Jackson Laboratory for Genomic Medicine faculty as professor and associate director of cancer immunology. Science magazine recognized cancer immunotherapy as the 'Breakthrough of the Year' in 2013, and Palucka is one of the leaders in this field. Her research exploits dendritic cells, which control the body’s immune response to tumors, as the basis for new vaccines against melanomas and other human cancers. In a recent interview in the journal Nature, Palucka described how she used this approach to treat the pancreatic cancer of Nobel prizewinner Ralph M. Steinman using dendritic cells—the very cells Steinman and colleagues had discovered.
Life Technologies Corporation and The Jackson Laboratory Sign agreement for TAL Technology
Nov 22 13
Life Technologies Corporation and The Jackson Laboratory, or JAX have signed an agreement enabling JAX to use Life's Transcription Activator-Like Effector technology, or TALs, to generate and market novel mouse disease models. Jackson Laboratory will also establish a program to maintain and distribute TAL-modified mice developed by researchers in pharma and academic labs. Life Technologies' patented TAL technology, marketed as GeneArt Precision TALs, enables targeting and binding of DNA sequences with high precision, permitting researchers to generate genetically modified mice quickly, easily and reliably. This relationship with Life Technologies will advance both and Life Technologies' goals in developing animal models that will advance understanding of human disease and help in the development of novel drugs.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|